Memantine-d6 (hydrochloride)
CAT:
804-HY-B0365AS-01
Size:
500 μg
For Laboratory Research Only. Not for Clinical or Personal Use.
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Memantine-d6 (hydrochloride)
Description:
Memantine-d6 (hydrochloride) is the deuterium labeled Memantine hydrochloride. Memantine (hydrochloride) (D-145 (hydrochloride) ) is a moderate affinity, uncompetitive NMDA receptor antagonist, inhibit CYP2B6 and CYP2D6 with Kis of 0.51 nM and 94.9 μM, respectively[1].UNSPSC:
12352211Target:
Autophagy; Cytochrome P450; iGluRType:
Isotope-Labeled CompoundsRelated Pathways:
Autophagy; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal SignalingField of Research:
Neurological DiseasePurity:
99.83Solubility:
10 mM in DMSOSmiles:
[2H]C ([2H]) ([2H]) [C@@] (C[C@@] (N) (C[C@@H]1C2) C3) (C1) C[C@@]32C ([2H]) ([2H]) [2H].ClMolecular Formula:
C12H16D6ClNMolecular Weight:
221.80References & Citations:
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Robinson, D.M. and G.M. Keating, Memantine: a review of its use in Alzheimer's disease. Drugs, 2006. 66 (11) : p. 1515-34.|[3]Chen, H.S., et al., Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci, 1992. 12 (11) : p. 4427-36.|[4]Chen, H.S. and S.A. Lipton, Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J Physiol, 1997. 499 (Pt 1) : p. 27-46.Shipping Conditions:
Blue IceStorage Conditions:
-20°C, 3 years (Powder)Scientific Category:
Isotope-Labeled CompoundsClinical Information:
No Development ReportedCAS Number:
1189713-18-5
